KBC Group
GH icon

KBC Group’s Guardant Health GH Stock Holding History

KBC Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$696K Buy
7,537
+4,403
+140% +$442K ﹤0.01% 757
2025
Q4 		$320K Hold
3,134
– – ﹤0.01% 782
2025
Q3 		$196K Hold
3,134
– – ﹤0.01% 911
2025
Q2 		$163K Sell
3,134
-2,503
-44% -$112K ﹤0.01% 947
2025
Q1 		$240K Sell
5,637
-21
-0.4% -$906 ﹤0.01% 970
2024
Q4 		$173K Buy
5,658
+2,200
+64% +$61.9K ﹤0.01% 1211
2024
Q3 		$79K Hold
3,458
– – ﹤0.01% 1443
2024
Q2 		$100K Hold
3,458
– – ﹤0.01% 1160
2024
Q1 		$71K Buy
3,458
+1,080
+45% +$23.2K ﹤0.01% 1323
2023
Q4 		$64K Hold
2,378
– – ﹤0.01% 1349
2023
Q3 		$70K Buy
+2,378
New +$83.6K ﹤0.01% 1188

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KBC Group's GH Position: Q1 2026 in Review

KBC Group increased its Guardant Health (GH) stake by 140% in Q1 2026, buying an estimated $442K and bringing the position to 7,537 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

KBC Group first reported a position in GH in Q3 2023 and has held it in 11 quarters since. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • KBC Group held 7,537 shares of Guardant Health worth $696K as of Q1 2026.
  • KBC Group bought 4,403 Guardant Health shares in Q1 2026, an estimated $442K.
  • Guardant Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #757 holding.
  • KBC Group first reported a position in Guardant Health in Q3 2023 and has held it in 11 quarters since.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.